Cargando…

Paraoxonase gene polymorphisms and haplotype analysis in a stroke population

BACKGROUND: Paraoxonase (PON) has anti-atherogenic activity due to its protective function against low density lipoprotein (LDL) oxidation. Alteration of enzyme activity due to polymorphisms in the PON genes may influence the development of atheroma and thus affect stroke risk. Three PON genes (PON1...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasdar, Alireza, Ross-Adams, Helen, Cumming, Alastair, Cheung, John, Whalley, Lawrence, St Clair, David, MacLeod, Mary-Joan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435875/
https://www.ncbi.nlm.nih.gov/pubmed/16551349
http://dx.doi.org/10.1186/1471-2350-7-28
_version_ 1782127283957399552
author Pasdar, Alireza
Ross-Adams, Helen
Cumming, Alastair
Cheung, John
Whalley, Lawrence
St Clair, David
MacLeod, Mary-Joan
author_facet Pasdar, Alireza
Ross-Adams, Helen
Cumming, Alastair
Cheung, John
Whalley, Lawrence
St Clair, David
MacLeod, Mary-Joan
author_sort Pasdar, Alireza
collection PubMed
description BACKGROUND: Paraoxonase (PON) has anti-atherogenic activity due to its protective function against low density lipoprotein (LDL) oxidation. Alteration of enzyme activity due to polymorphisms in the PON genes may influence the development of atheroma and thus affect stroke risk. Three PON genes (PON1, PON2 and PON3) have been identifiedand mapped to chromosome 7. METHODS: We looked at the distribution of paraoxonase polymorphisms and haplotype arrangement in 397 Caucasian ischaemic stroke patients and 405 controls. We investigated 6 different common single nucleotide polymorphisms (SNP) in PON genes; two substitutions in PON1 ["A/G": Gln (Q)/Arg (R)] at codon 192 and ["T/A": Leu (L)/Met (M)] at codon 55, two in PON2 at codon 311 ["G/A": Cys (C)/Ser (S)] and codon 148 ["C/G": Ala (A)/Gly (G)] and two SNPs, both "A" to "G" substitutions, in PON3 – intronic rs2074353, which we designated PON3-1 and [Ala (A)/Ala (A)] at codon 99, designated as PON3-3. Dynamic Allele Specific Hybridisation (DASH) was used as the genotyping assay. Haplotype analysis was performed using both PHASE and EHPLUS programs. RESULTS: Genotype and allele frequencies were similar in cases and controls. Lipid profiles were not influenced by PON genotype. Haplotype frequencies for the six loci (PON2-148, PON2-311, PON3-3, PON3-1, PON1-55 and PON1-192) were estimated. Comparison of the two programs showed a significant difference in haplotype arrangements with EHPLUS (p-value = 0.005) but not with PHASE Ver.2 (p-value = 0.12). The 112211 (1 = frequent allele, 2 = rare allele) haplotype arrangement was commoner in cases than controls (p = 0.015), and the 111121 haplotype was commoner in controls (p = 0.006). CONCLUSION: Our study did not identify a role for individual paraoxonase gene polymorphisms in the pathogenesis of ischaemic stroke. Findings of haplotype differences should be confirmed in large scale studies. The importance of using a well-validated haplotype analysis program is also underlined.
format Text
id pubmed-1435875
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14358752006-04-14 Paraoxonase gene polymorphisms and haplotype analysis in a stroke population Pasdar, Alireza Ross-Adams, Helen Cumming, Alastair Cheung, John Whalley, Lawrence St Clair, David MacLeod, Mary-Joan BMC Med Genet Research Article BACKGROUND: Paraoxonase (PON) has anti-atherogenic activity due to its protective function against low density lipoprotein (LDL) oxidation. Alteration of enzyme activity due to polymorphisms in the PON genes may influence the development of atheroma and thus affect stroke risk. Three PON genes (PON1, PON2 and PON3) have been identifiedand mapped to chromosome 7. METHODS: We looked at the distribution of paraoxonase polymorphisms and haplotype arrangement in 397 Caucasian ischaemic stroke patients and 405 controls. We investigated 6 different common single nucleotide polymorphisms (SNP) in PON genes; two substitutions in PON1 ["A/G": Gln (Q)/Arg (R)] at codon 192 and ["T/A": Leu (L)/Met (M)] at codon 55, two in PON2 at codon 311 ["G/A": Cys (C)/Ser (S)] and codon 148 ["C/G": Ala (A)/Gly (G)] and two SNPs, both "A" to "G" substitutions, in PON3 – intronic rs2074353, which we designated PON3-1 and [Ala (A)/Ala (A)] at codon 99, designated as PON3-3. Dynamic Allele Specific Hybridisation (DASH) was used as the genotyping assay. Haplotype analysis was performed using both PHASE and EHPLUS programs. RESULTS: Genotype and allele frequencies were similar in cases and controls. Lipid profiles were not influenced by PON genotype. Haplotype frequencies for the six loci (PON2-148, PON2-311, PON3-3, PON3-1, PON1-55 and PON1-192) were estimated. Comparison of the two programs showed a significant difference in haplotype arrangements with EHPLUS (p-value = 0.005) but not with PHASE Ver.2 (p-value = 0.12). The 112211 (1 = frequent allele, 2 = rare allele) haplotype arrangement was commoner in cases than controls (p = 0.015), and the 111121 haplotype was commoner in controls (p = 0.006). CONCLUSION: Our study did not identify a role for individual paraoxonase gene polymorphisms in the pathogenesis of ischaemic stroke. Findings of haplotype differences should be confirmed in large scale studies. The importance of using a well-validated haplotype analysis program is also underlined. BioMed Central 2006-03-21 /pmc/articles/PMC1435875/ /pubmed/16551349 http://dx.doi.org/10.1186/1471-2350-7-28 Text en Copyright © 2006 Pasdar et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pasdar, Alireza
Ross-Adams, Helen
Cumming, Alastair
Cheung, John
Whalley, Lawrence
St Clair, David
MacLeod, Mary-Joan
Paraoxonase gene polymorphisms and haplotype analysis in a stroke population
title Paraoxonase gene polymorphisms and haplotype analysis in a stroke population
title_full Paraoxonase gene polymorphisms and haplotype analysis in a stroke population
title_fullStr Paraoxonase gene polymorphisms and haplotype analysis in a stroke population
title_full_unstemmed Paraoxonase gene polymorphisms and haplotype analysis in a stroke population
title_short Paraoxonase gene polymorphisms and haplotype analysis in a stroke population
title_sort paraoxonase gene polymorphisms and haplotype analysis in a stroke population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435875/
https://www.ncbi.nlm.nih.gov/pubmed/16551349
http://dx.doi.org/10.1186/1471-2350-7-28
work_keys_str_mv AT pasdaralireza paraoxonasegenepolymorphismsandhaplotypeanalysisinastrokepopulation
AT rossadamshelen paraoxonasegenepolymorphismsandhaplotypeanalysisinastrokepopulation
AT cummingalastair paraoxonasegenepolymorphismsandhaplotypeanalysisinastrokepopulation
AT cheungjohn paraoxonasegenepolymorphismsandhaplotypeanalysisinastrokepopulation
AT whalleylawrence paraoxonasegenepolymorphismsandhaplotypeanalysisinastrokepopulation
AT stclairdavid paraoxonasegenepolymorphismsandhaplotypeanalysisinastrokepopulation
AT macleodmaryjoan paraoxonasegenepolymorphismsandhaplotypeanalysisinastrokepopulation